Steven Mah is a director and senior research analyst at Piper Sandler covering the Diagnostics & Life Science Tools sector.　Prior to joining the sell-side, Mah spent 13 years in Piper Sandler’s Healthcare investment banking group, covering a broad range of investment banking activities in the Diagnostics and Life Sciences Tools space, including mergers & acquisitions, public and private financings.　Before beginning his investment banking career, Mah was a scientist and program manager at Sequenom.　Mah earned a doctorate in molecular biology from the Salk Institute and graduated with a bachelor’s degree in molecular biology from UCLA and received a Master of Business Administration degree from the Johnson School of Business at Cornell University.